Human cytomegalovirus-induced immunosuppression: Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes

Journal of Clinical Investigation

Volumn 97, Issue 11, 1996, Pages 2635-2641

  Nokta, Mostafa A ^a   Hassan, Mahmound I ^a   Loesch, Kimberly ^a   Pollard, Richard B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cytokines; Immunosuppression; PGE2; TNF ; Viruses

Indexed keywords

ARACHIDONIC ACID; CYCLIC AMP; INDOMETACIN; PENTOXIFYLLINE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ARACHIDONIC ACID; CELLS, CULTURED; CYCLIC AMP; CYCLOHEXIMIDE; CYTOMEGALOVIRUS; DINOPROSTONE; HUMANS; IMMUNE TOLERANCE; INDOMETHACIN; INTERLEUKIN-2; KINETICS; LYMPHOCYTE ACTIVATION; MONOCYTES; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029938463     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118713     Document Type: Article

References (39)

1. Meyers, J.D., N. Flournoy, and E.D. Thomas. 1982. Nonbacterial pneumonia of the allogeneic marrow transplantation: a review of ten years experience. Rev. Infect. Dis. 4:1119-1132.
2. Neiman, P.E., W. Reeves, G. Ray, N. Flournoy, R.G. Lerner, G.E. Sale, and E.D. Thomas. 1977. A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogenic bone marrow grafts. J. Infect. Dis. 136:754-767.
3. Stinson, E.B., C.P. Bieber, R.B. Griepp, D.A. Clark, N.E. Shumway, and J.S. Remington. 1971. Infectious complications after cardiac transplantation in man. Ann. Intern. Med. 74:22-36.
4. Hill, R.B., Jr., D.T. Rowlands, and D. Rifkind. 1964. Infectious pulmonary disease in patients receiving immunosuppressive therapy for organ transplantation. N. Engl. J. Med. 271:1021-1027.
5. Stover, D.E., D.A. White, P.A. Romano, R.A. Gellene, and W.A. Robeson. 1985. Spectrum of pulmonary diseases associated with the acquired immunodeficiency syndrome. Am. J. Med. 78:429-437.
6. Emanuel, D., J. Peppard, B.S.D. Stoever, J. Gold, D. Armstrong, and U. Hammerling. 1986. Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies. Ann. Int. Med. 104:476-481.
7. Wallace, J.M., and J. Hannah. 1985. Cytomegalovirus pneumonitis in patients with AIDS. Chest. 9212:198-203.
8. Quinnan, G.V., Jr., H. Masur, A.H. Rook, G. Armstrong, W.R. Frederick, J. Epstein, J.F. Manischewitz, A.M. Macher, L. Jackson, J. Ames, et al. 1984. Herpes virus infections in the acquired immunodeficiency syndrome. JAMA (J. Am. Med. Assoc.). 52:72-76.
9. Rinaldo, C.R., Jr., W.P. Carney, B.S. Richter, P.H. Black, and M.S. Hirsch. 1980. Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J. Infect. Dis. 141:488-495.
10. Carney, W.P., and M.S. Hirsch. 1981. Mechanisms of immunosuppression in cytomegalovirus mononucleosis II. Virus-monocyte interactions. J. Infect. Dis. 144:47-54.
11. Schrier, R.D., J.A. Nelson, and M.B. Oldstone. 1985. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science (Wash. DC). 230:1048-1051.
12. Albrecht T, I. Boldogh, M. Fons, S. Abubakar, and C.Z. Deng. 1990. Cell activation signals and the pathogenesis of human cytomegalovirus. Intervirology. 31(2-4):68-75.
13. 3H]-arachidonic acid prelabeled cells. Arch. Virol. 113(3-4):255-266.
14. 2 and protein kinase C. Biochem. Biophys. Res. Commun. 166:953-959.
15. Hassan, M.I., M.A. Nokta, and R.B. Pollard. 1993. Involvement of cAMP and protein kinase C in cytomegalovirus enhancement of human immunodeficiency virus replication. Proc. Soc. Exp. Biol. Med. 204:216-223.
16. Skolnik, P.R., B.R. Kosloff, and M.S. Hirsch. 1988. Bidirectional interactions between human immunodeficiency virus type I and cytomegalovirus. J. Infect. Dis. 157:508-514.
17. Lathey, J.L., D.H. Spector, and S.A. Spector. 1994. Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocytes-derived macrophages. Virology. 199:98-104.
18. Peterson, P.K., G. Gekker, C.C. Chao, S. Hu, C. Edeiman, H.H. Balfour, and J. Verhoef. 1992. Human cytomegalovirus-stimulated peripheral blood mononuclear cells HIV-1 replication via a tumor necrosis factor-α-mediated mechanism. J. Clin. Invest. 89:574-580.
19. Dudding, L., S. Haskil, B.D. Clark, P.E. Auron, S. Sporn, and E.S. Huang. 1989. Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. J. Immunol. 143:3343-3352.
20. Ibanez, C., R. Schrier, P. Ghazal, C. Wiley, and J. Nelson. 1991. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65:6581-6388.
21. Nokta, M., C. Lee, O.S. Steinsland, and T. Albrecht. 1984. Inhibition of cytomegalovirus induced cytomegaly and nuclear inclusions by cyclic nucleotide modulators. In Herpesviruses. F. Rapp and R. Alan, editors. Liss Inc. New York. 465-475.
22. Wentworth, B.B., and L. Grench. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135:253-258.
23. Rice, G. 1986. Role of the monocyte in cytomegalovirus-mediated immunosuppression in vitro. J. Infect. Dis. 154:881-884.
24. 2 as methyloxime by radioimmunoassay using a novel iodinated label. Prostaglandins Leukot. Essent. Fatty Acids. 37:187-191.
25. Gilbert, K.M. and M.K. Hoffman. 1985. cAMP is an essential signal in the induction of antibody production by B-cells but inhibits helper function of T-cells. J. Immunol. 135:2084-2089.
26. Parker, C.W. 1979. Role of cyclic nucleotides in regulatory lymphocytes. Ann. NY. Acad. Sci. 332:255-300.
27. Baker, P.E., J.V. Fahey, and A. Munck. 1981. Prostaglandin inhibition of T-cell proliferation is mediated at two levels. Cell. Immunol. 61:52-61.
28. Muscoplat, C.C., D.J. Klausner, and C.J. Brunner. 1979. Regulation of mitogen and antigen-stimulated lymphocyte blastogenesis by prostaglandins. Infect. Immunol. 26:311-315.
29. 2+ responses in cytomegalovirus-infected fibroblasts of human origin. Virology. 157: 259-267.
30. Maciejewski, J.P., E.E. Bruening, R.E. Donahue, S.E. Sellers, C. Carter, N.S. Young, and S. St. Jeor. 1993. Infection of mononucleated phagocytes with human cytomegalovirus. Virology. 195:327-336.
31. Paya, C.V., J.L. Vireliziev, and S. Michelson. 1991. Modulation of T-cell activation through protein kinase C or A-dependent signaling pathways synergistically increases human immunodeficiency virus long terminal repeat induction by cytomegalovirus immediate early proteins. J. Virol. 65:5477-5484.
32. Pfeilschifter, J., W. Pignat, K. Vosbeck, and F. Marki. 1989. Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochem. Biophys. Res. Commun. 159:385-394.
33. Clark, M.A., M.-J. Chen, S.T. Crokke, and J.S. Bomalaski. 1988. Tumor necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem. J. 250:125-132.
34. Bachwich, P.R., S.W. Chensue, J.W., Larrick, and S.L. Kunkel. 1986. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. Biochem. Biophys. Res. Commun. 36:94-101.
35. Haagmans, B.L., F.S. Stals, P.H. Vand der Meide, C.A. Bruggeman, M.C. Horzinek, and V.E. Schijns. 1994. Tumor necrosis factor alpha promotes replication and pathogenicity of rat cylomegalovirus. J. Virol. 68:2297-2304.
36. Dobrescu, D., B. Ursea, M. Pope, A.S. Asch, and D.N. Posnett. 1995. Enhanced HIV-1I replication in Vβ-12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell, 82:753-763.
37. Ramis, I., J.R. Catafau, and G. Gomez. 1991. Cyclooxygenase and lipoxygenase arachidonic acid metabolism by monocytes from human immunodeficiency virus-infected drug users. J. Chromatog. 557:507-513.
38. Goodwin, J.S., and J. Ceuppens. 1983. Regulation of immune response by prostaglandins. J. Clin. Immunol. 3:295-315.
39. Stockpool, A., and J. Mertin. 1981. The effect of prostaglandin precursors in vivo models of cell-mediated immunity. Prog. Lipid. Res. 20:649-654.